Use of the Information. 1. Information if transmitted with a purpose may be used only for the purpose for which it was transmitted and any restriction on its use, deletion or destruction, including possible access restrictions in general or specific terms must be respected by the Parties.
2. Use of information for a different purpose than the purpose for which the information was transmitted must be authorised by the transmitting Party.
Use of the Information. Restrictions on Use of the Information by the Licensee and Licensee’s Users The Licensee including the Licensee’s Users may not make any compilations store, distribute, make available to any third parties, or reproduce any of the Information or further create, compile, store, make available to any third parties or distribute any Value Added Information. The Licensee shall notify the Licensee’s Users that they must use the Information strictly in accordance with the provisions of Clause 8.1.
Use of the Information. 2.1 The Recipient shall treat the Confidential Information and the fact that the Discloser has supplied the Confidential Information as private and confidential.
2.2 With effect on the date of this AGREEMENT, the Recipient shall not disclose or allow to be disclosed any Confidential Information except:
(a) as required by law or by a stock exchange or by any order of any court, tribunal, authority or regulatory body;
(b) to its Associates or professional advisers to the extent that they have a need to know the Confidential Information for the Disclosure Purpose; or
(c) to any other person to whom the Discloser has consented in writing prior to the disclosure that the Confidential Information may be disclosed (such consent not to be unreasonably withheld).
2.3 The Recipient shall not use the Confidential Information nor allow the Confidential Information to be used in a manner detrimental to the Discloser or any of its Related Body Corporates.
2.4 The Recipient must ensure that all Confidential Information in the possession of the Recipient or any of its Associates or professional advisers is only used for the Disclosure Purpose.
2.5 If there is any uncertainty as to whether any information is Confidential Information, that information must be treated as Confidential Information unless the Discloser notifies the Recipient in writing to the contrary.
2.6 The Recipient must:
(a) maintain effective security measures to protect all Confidential Information from unauthorized access, use, copying or disclosure;
(b) notify the Discloser immediately in writing if the Recipient becomes aware of any possible or actual breach of this AGREEMENT and take all reasonable steps required to prevent or stop that breach, at the Recipient’s expense; and
(c) reasonably assist the Discloser in connection with any action or investigation by the Discloser regarding any possible or actual unauthorized disclosure or misuse of the Confidential Information.
Use of the Information. We may use the information provided by You in the following ways, viz: Monitor, improve and administer our Website.
Use of the Information. 1.1. We acknowledge that for the purposes of the Act, we are the data processor and you are the data controller of the Information. Both those terms are defined in the Act.
1.2. We will process the Information only to the extent, and in such a manner, as is necessary for the purposes of the Contract and in accordance with our instructions from time to time. We will not process the Information for any other purpose. You will keep a record of any processing of Information that we carry out on your behalf.
1.3. We will promptly comply with any request from you requiring us to amend, transfer or delete the Information. We must do this even after the agreement has ended.
1.4. If we receive any complaint, notice or communication which relates directly or indirectly to the processing of the Information or to the compliance of either of us with the Act, we will notify you immediately and provide you with full co-operation and assistance in relation to that complaint, notice or communication.
1.5. At your request, we will provide you with a copy of all Information held by you in the format and on the media you reasonably specify. We must do this even after the agreement has ended.
1.6. We will not transfer the Information outside the European Economic Area without your prior written consent.
1.7. We will promptly inform you if any Information is lost or destroyed or becomes damaged, corrupted, or unusable. We will restore that Information at our own expense.
Use of the Information. ICES shall use the personal health information collected under this agreement only as neces- sary for the following purposes:
3.1. To link the OHC RHS Database with the Registered Person Database (RPDB) to create a cohort of First Nations people living in Xxxxxxxx and Inuit and Métis people living in Ottawa. This cohort will be linked with the other administrative data, and a variety of measures will be determined and analyses will be conducted for the First Nations cohort in Xxxxxxxx and the Inuit and Métis cohort in Ottawa. These may include, but will not be limited to:
3.1.1. The incidence and prevalence of chronic diseases such as diabetes, cardiovas- cular disease, arthritis, COPD, cancer, and stroke.
Use of the Information. Section A-1 Users are defined as the State Medicaid Agencies and downstream entities that are Health Insurance Portability and Accountability Act (HIPAA) Covered Entities that are given individually identifiable data to carry out care coordination and quality improvement work, as well as the business associates of such entities and any sub-contractor Business Associates of such entities. Users may include providers and care coordination organizations that wish to use individually identifiable data about beneficiaries of the Medicare and Medicaid programs (Medicare- Medicaid enrollees) to provide care coordination and quality improvement programs on behalf of the State Medicaid Agency and/or one or more HIPAA Covered Entity providers. Such work would need to be done subject to a HIPAA business associate agreement with that State Medicaid Agency and/or those HIPAA Covered Entity providers. The Users must use any individually identifiable information that they receive under A-1 to further the delivery of seamless, coordinated care for individuals who are Medicare-Medicaid enrollees to promote better care, better health, and lower growth in expenditures.
Section A-2 Subject to the limitations described below, users may reuse original or derivative data from the files specified in Section 5 of the Data Use Agreement, with or without direct identifiers, without prior written authorization from CMS, for clinical treatment, case management and care C MS’s Senior Agency Official for Privacy website (xxxx://xxx.xxx.xxx.xxx/privacy), as well as other permitted disclosures found in the Privacy Act at 5 U.S.C. § 552a(b)(1) through (b)(12). Section A-3 Nothing in the Data Use Agreement, including but not limited to Section 9, governs the use and/or disclosure of any information that is obtained independent of the Data Use Agreement, regardless of whether the information was also obtained or could also be derived from the files specified in Section 5 of the Data Use Agreement.
Section A-4 Users are expressly authorized to undertake further investigation into events and individuals related to the files specified in Section 5 in a manner consistent with Section A-2. This includes, but is not limited to, reviewing other records, interviewing individuals, and attempting to link the files specified in Section 5 to other files.
Use of the Information. Users are defined as the State Medicaid Agencies and downstream entities that are Health Insurance Portability and Accountability Act (HIPAA) Covered Entities that are given individually identifiable data to carry out care coordination and quality improvement work, as well as the business associates of such entities and any sub-contractor Business Associates of such entities. Users may include providers and care coordination organizations that wish to use individually identifiable data about beneficiaries of the Medicare and Medicaid programs (Medicare- Medicaid enrollees) to provide care coordination and quality improvement programs on behalf of the State Medicaid Agency and/or one or more HIPAA Covered Entity providers. Such work would need to be done subject to a HIPAA business associate agreement with that State Medicaid Agency and/or those HIPAA Covered Entity providers. The Users must use any individually identifiable information that they receive under A-1 to further the delivery of seamless, coordinated care for individuals who are Medicare-Medicaid enrollees to promote better care, better health, and lower growth in expenditures.
Use of the Information. 6.1 The Information will be used solely for the purposes of the Act, that is, for statistical and research purposes only.
6.2 An important statistical use of administrative data is Microdata Linkage. Statistics Canada undertakes Microdata Linkages only in cases where the public good is clearly evident and outweighs any privacy intrusiveness. Statistics Canada's Directive on Microdata Linkage describes the approval process required prior to engaging in Microdata Linkage activities. In most cases, the non-confidential statistical outputs from these projects are published by Statistics Canada.
Use of the Information. The CONFIDENTIAL INFORMATION received from one Contractual Party may only be used by the other for the purpose for which it has been made available. Continuing use is only permitted if the other Contractual Party has provided written permission in advance. Each Contractual Party is obligated to ensure that transmitted data does not cause any damage or losses etc. in the receiver systems, for example, due to computer viruses. Incoming and outgoing data must be examined with up-to-date virus protection programs. If a Contractual Party detects faults or factors impairing operation such as computer viruses, or has a justified reason to suspect such an occurrence, then it must inform the other Party immediately. Irrespective of the notification obligation, each Contractual Party must in such a case take all measures available to it for minimizing damages, identifying and avoiding errors.
